Global Metered Dose Inhalers Report - Analysis, Technologies & Opportunities 2016-2022

Friday, March 11, 2016 12:57 PM UTC

Dublin, March 11, 2016 -- Research and Markets (http://www.researchandmarkets.com/research/rhvbfw/metered_dose) has announced the addition of the "Metered Dose Inhalers to 2022" report to their offering.

This report examines the current and future metered dose inhalers market and the key topics all market participants should be aware of. Recent improvements in the control of the inspiry event have reduced the need for add-on devices designed to help regulate patient administration. Growth in upper airway therapeutics will help to push MDI unit demand to high single digits between now and the end of the decade.

Questions Answered:

What inhalable drugs are supplied in MDIs, how are they marketed, what are the device specifics, and who markets them?
What inhalable MDI products are in late stage development, who are the developers, and what indications are they targeting?
What are the major factors driving metered dose inhaled drug/device demand?
What is the size of the market today, who are the market share leaders, and what will the market share be in 2022?
How important are drug developer-device manufacturer relationships and what are the key alliances in the industry?
What are the essential design factors, material selection issues, technologies and market development issues MDI products?
What are the significant economic, technology, and regulatory factors affecting the market for MDIs?

Report Structure:

1. Executive Summary

2. Inhaled Drug Delivery Market Dynamics

3. Devices and Formulations

4. MDI Technology Factors

5. MDI Performance Factors

6. MDI Product Assessments and Analysis

7. Therapeutic Market Analysis, Market Data and Forecasts

8. Market Factors

9. Company Profiles

For more information visit http://www.researchandmarkets.com/research/rhvbfw/metered_dose


CONTACT: Research and Markets
         Laura Wood, Senior Manager
         [email protected]

         For E.S.T Office Hours Call 1-917-300-0470
         For U.S./CAN Toll Free Call 1-800-526-8630
         For GMT Office Hours Call +353-1-416-8900

         U.S. Fax: 646-607-1907
         Fax (outside U.S.): +353-1-481-1716

         Sector: Inhalers and Nebulisers, Respiratory Devices

Editor's Picks

Breathing through your nose when you exercise may make your runs easier

Entrepreneurs are facing a mental health crisis — here's how to help them

Are fish oil supplements as healthy as we think? And is eating fish better?

Will AI kill our creativity? It could – if we don’t start to value and protect the traits that make us human

Does AI have a right to free speech? Only if it supports our right to free thought

How can I lower my cholesterol? Do supplements work? How about psyllium or probiotics?

Why we need to set limits on sperm donation

Aging with a healthy brain: How lifestyle changes could help prevent up to 40% of dementia cases

Seven techniques to avoid weight regain, approved by experts

Global Metered Dose Inhalers Report - Analysis, Technologies & Opportunities 2016-2022

Editor's Picks

Welcome to EconoTimes